S100A12 | MRP8/14* | hsCRP | S100A12 or hsCRP | MRP8/14 or hsCRP | ||||||
---|---|---|---|---|---|---|---|---|---|---|
<175 ng/ml | ≥175 ng/ml | <690 ng/ml | ≥690 ng/ml | <0.3 mg/dl | ≥0.3 mg/dl | S100A12 <175 ng/ml and hsCRP <0.3 mg/dl | S100A12 ≥175 ng/ml or hsCRP ≥0.3 mg/dl | MRP8/14 <690 ng/ml and hsCRP <0.3 mg/dl | MRP8/14 ≥690 ng/ml or hsCRP ≥0.3 mg/dl | |
Number of patients | 150 | 38 | 113 | 75 | 159 | 27 | 132 | 54 | 101 | 85 |
Number of flares within 0–3 months | 5 | 10 | 2 | 13 | 10 | 4 | 3 | 11 | 1 | 13 |
Number of flares within 0–6 months | 19 | 16 | 13 | 22 | 23 | 11 | 12 | 22 | 8 | 26 |
Number of flares within 0–12 months | 45 | 23 | 31 | 37 | 52 | 15 | 36 | 31 | 24 | 43 |
Number of flares after 12 months | 22 | 2 | 14 | 10 | 22 | 2 | 20 | 4 | 13 | 11 |
Overall number of flares | 67 | 25 | 45 | 47 | 74 | 17 | 56 | 35 | 37 | 54 |
↵* Some of the data on MRP8/14 have been previously reported.7
hsCRP, high-sensitivity C reactive protein.